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Abstract 
Study Design. Prospective, multicenter cohort study. 
Objective. The aim of our study was to assess the course of patients over a period of three 
years undergoing surgical or non-surgical treatments for degenerative lumbar spinal stenoses 
(DLSS) based on data from the Lumbar Stenosis Outcome Study (LSOS), prospectively 
performed in eight hospitals. 
Summary of Background Data. The optimal treatment strategy for patients with DLSS is 
still debated. 
Methods. The outcomes of patients with verified DLSS were quantified by Spinal Stenosis 
Measure (SSM) symptoms- and SSM function-scores, and EQ-5D-3L (quality of life) 
summary index (SI) over time (up to 36-month follow-up), and minimal clinically important 
difference (MCID) in SSM symptoms, SSM function, and EQ-5D-3L SI from baseline to 36-
month follow-up. 
Results. For this study, 601 patients met the inclusion criteria; 430 underwent surgery, 18 of 
them only after more than a year after enrolment, 171 received non-surgical treatment only. 
At baseline, patients in the surgical and nonsurgical groups had similar values for the SSM 
symptoms and SSM function scores, but patients in the surgical group suffered significantly 
more from buttocks pain and reported more worsening symptoms over the last three months 
before enrollment in the study. Surgically treated patients (except changers) performed 
significantly better in all clinical outcome measures (p<0.001) with a plateau at 12-month 
follow-up staying constant until the follow-up ended. Further, two thirds of patients in the 
Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
surgical group had a relevant improvement in function, symptoms, and quality of life, 
compared to only about half of those in terms of symptoms and even less in terms of function 
and quality of life with non-surgical treatment. 
Conclusions. Surgical treatment of DLSS results in more favorable clinical outcomes with a 
sustained effect over time, compared to non-surgical treatment. 
Key Words: clinical meaningful improvement; decompression; degenerative lumbar spinal 
stenosis; Fusion; long-term; MCID; multi-center; non-surgical; Quality of life; SSM 
Level of Evidence: 3 
Key Points 
• The optimal treatment strategy for patients with degenerative lumbar spinal stenoses 
is still debated. 
• At baseline patients in the surgical and nonsurgical groups had similar values for the 
Spinal Stenosis Measure (SSM) symptoms and SSM function scores, but patients in 
the surgical group suffered significantly more from buttocks and/or leg pain, reported 
more worsening symptoms over the last three months before enrollment in the study, 
responded poorer to pain medications, and had more levels with concomitant 
degenerative spondylolisthesis. 
• Two thirds of patients in the surgical group had a relevant improvement in function, 
symptoms, and quality of life after three years, compared to only about half of those 
in the non-surgical group in terms of symptoms and even less in terms of function and 
quality of life with non-surgical treatment. 
 
 
Introduction 
Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Degenerative lumbar spinal stenosis (DLSS) is a highly prevalent condition and causes 
considerable pain and disability.1 The underlying somatic anomaly is narrowing of the 
lumbar spinal canal by bulging discs, hypertrophy of surrounding bone and overgrowth of 
soft tissues that compromise neural and vascular elements.2 Patients typically complain of 
pain in the buttocks and lower extremities provoked by walking or extended standing and 
relieved by rest or bending forward.2,3 
The treatment options range from non-surgical approaches such as analgesics, 
physiotherapy, and epidural corticosteroid injections to surgical methods. In the last few 
decades, the number of surgical procedures to treat DLSS has worldwide increased steadily4-7 
– in particular in patients older than 65 years of age8 – despite debates on mid- to long-term 
improvement in pain or disability9-11 and a potential higher economic burden of surgery.4 
Despite of an impressive number of published studies,9,11-23 the best treatment strategy for 
patients with DLSS is still a matter of debate. As stated by the authors of a Cochrane review24 
it appears to be uncertain whether surgical or non-surgical treatment leads to better results in 
patients with lumbar spinal stenosis. Evidence on the benefit of the non-surgical treatments is 
lacking or scarce, except for a short-term improvement of symptoms after epidural injections 
of steroids and analgesics.25 After surgery about one third of the patients report no relevant 
improvement of symptoms and rates of reoperations range between 6% and 15% within two 
to five years11,22,26-28 after decompression-alone or after decompression and fusion 
surgery.26,29 
The aim of our study was to assess the course of patients over a period of three years 
undergoing surgical or non-surgical treatments for DLSS based on data from the Lumbar 
Stenosis Outcome Study (LSOS), a multicenter Swiss cohort study. 
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Material and Methods 
Study design and inclusion criteria 
This study was conducted in compliance with international laws and regulations as well as 
any applicable guidelines. The study was approved by the independent Ethics Committee of 
the Canton Zurich (KEK-ZH-NR: 2010-0395/0). Written informed consent to participate in 
the study has been obtained from participants.  
The Lumbar Stenosis Outcome Study (LSOS) is a multicenter initiative, conducted as a 
prospective cohort study in the Rheumatology and Spine Surgery Units at eight medical 
centers (which service a region in Switzerland with approximately two million inhabitants) 
and includes data of 679 patients documented over a period of 3 years in a prospective 
manner.30 Patients were included into this study if they were 50 years or older and had a 
diagnosis of DLSS verified by Magnetic Resonance Imaging (MRI) or Computer 
Tomography (CT) with symptoms of neurogenic claudication. Patients were excluded if the 
stenosis was caused by tumor, fracture, infection, or significant deformity (>15° lumbar 
scoliosis, diagnosed on conventional x-ray with anterior-posterior and lateral views) or with a 
history of previous spinal surgery. Further exclusion criterion was symptomatic peripheral 
artery occlusive disease. 
 
Treatment 
The choice of the treatment strategy (non-surgical or surgical) was made by the attending 
physician based on patients’ symptoms and preferences. Non-surgical therapy consisted of 
analgesics, physiotherapy, and/or lumbar epidural/nerve root/facet joint injection (of steroids 
and/or analgesics). 
Surgical patients underwent either decompression alone or decompression with 
instrumented fusion surgery. Decompression surgery consisted of a standard open or 
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microscopic posterior lumbar decompression (laminotomy) of the affected level(s). 
Decompression of the lateral recess and the foramina was performed when necessary to 
decompress the exciting nerve roots. Fusion surgery consisted of decompression surgery and 
pedicle screws instrumentation with or without intercorporal cage(s) at the affected level(s). 
It was at the discretion of the surgeons to add fusion and to proceed with single- or multi-
level procedures, based on patients’ symptoms and MRI-findings.  
 
Outcome Measures 
The outcomes of our study were quantified by Spinal Stenosis Measure (SSM) symptoms and 
SSM function scores, and EQ-5D-3L (quality of life) summary index (SI) over time 
(measured at baseline, 12-, 24-, and 36-month follow-up), and minimal clinically important 
difference (MCID) in SSM symptoms, SSM function, and EQ-5D-3L SI from baseline to 36-
month follow-up. 
Spinal Stenosis Measure (SSM): The SSM is a self-administered validated three-part 
questionnaire that was specifically designed for DLSS patients to measure the severity of 
symptoms and disability.31 It is widely used in studies on DLSS23,32-34 and recommended by 
the North American Spine Society (NASS). It consists of three different subscales; the 
symptom severity subscale, the physical function subscale and the satisfaction subscale. The 
subscale score ranges are 1−5, 1−4 and 1−4 (best-worst). MCID for SSM symptoms is 
defined as an improvement (decrease) by at least 0.48 points, and for SSM function by at 
least 0.52 points.35  
EQ-5D-3L: The EuroQol five-dimensional questionnaire (EQ-5D) is a standardized 
instrument to measure health-related quality of life (HRQOL) and was developed by the 
EuroQol Group.36 The first element, the EQ-5D descriptive system, measures the health state 
in five dimensions (mobility, self-care, usual activities, pain/discomfort, and 
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anxiety/depression), with three levels of severity for each dimension (EQ-5D-3L).36 The five 
dimensions can be reported as a single 5-digit number (from 11111 representing full health to 
33333, meaning worst health). With help of a value set (depending on population norms), the 
health state can be converted into a single summary index (SI) value. This value can range 
from -0.53 (for the French population) to 1, with 0 representing a health state equivalent to 
being dead and 1 indicating full health. MCID is defined as an improvement (increase) by at 
least 0.19 points [article submitted, under review]. The second element, the EQ-5D Visual 
Analogue Scale (VAS), measures the health status on a vertical scale between 0 and 100 
(worst to best imaginable health state) on a particular day. 
 
Morphological data based on MRI 
Two senior radiologists assessed the MRI of each patient according to the consensus paper of 
Andreisek et al.37 Three core parameters were used to verify and to describe the severity of 
lumber spinal stenosis (Appendix Table 1): 1) compromise of the central zone,38 2) relation 
between fluid and cauda equina (Schizas classification),39 and 3) nerve root compression in 
the lateral recesses.40 Further parameters used were compromise of the foraminal zone38 and 
foraminal nerve root impingement.41 The Meyerding classification was used to grade the 
severity of the spondylolisthesis.42  
 
Statistical analysis 
Summary tables report count (percentage), mean (standard deviation) and median 
(interquartile range) as appropriate and with P-values from chi-squared, ANOVA or Kruskal-
Wallis tests correspondingly. Non-parametric Kruskal-Wallis tests are used to test for 
differences in improvement between treatment groups and types of surgery in unadjusted 
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analyses and chi-squared tests to compare proportions of patients reaching MCID. Further 
investigation of the potential differences due to treatment and other risk factors is done with 
linear models for the outcomes at 36 months. The models include treatment group, baseline 
score of the respective outcome, age, sex, diabetes, low education, civil risk, BMI, smoker, 
pain duration, Hospital Anxiety and Depression Scale (HADS, depression subscore), 
coxarthrosis, gonarthrosis, Cumulative Illness Rating Scale (CIRS), buttocks pain, leg pain, 
disease progression, degenerative spondylolisthesis, and number of stenotic levels.  
All analyses are conducted with R for Windows.43  
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Results 
Baseline patient characteristics 
Between December 2010 and December 2015, 841 patients agreed to participate in the LSOS 
study (Figure 1). Of these, 114 patients had history of spinal surgery prior to baseline and 48 
had no MRI examination, therefore they were excluded from this analysis. Of the remaining 
679 patients, 436 (64.2%) underwent initial surgery during the first year (surgical group), 225 
(33.1%) had non-surgical treatments only (non-surgical group), and 18 (2.7%) were first 
treated non-surgically and all underwent surgery after the first year of enrollment (changers 
group). Seventy-nine (11.6%) patients dropped out before 12-month follow-up (for reasons 
see Appendix Table 2). 
Table 1 presents the patient characteristics at baseline for patients in each group who had 
at least 12-month follow-up (n = 601). Overall, patients who underwent surgery within the 
first year were slightly younger, had a lower civil risk, suffered significantly more from 
buttocks and/or leg pain, had less coxarthrosis or gonarthrosis, and reported more worsening 
symptoms over the last 3 months with a higher degree of dissatisfaction with their quality of 
life (EQ-5D-3L SI) at baseline. 
 
Morphological findings on MRI 
The morphological evaluation on MRI is shown in Table 2. The most stenotic levels (at least 
one moderate grading in one of the three core parameters) were L4/5 followed by L3/4. Most 
patients had moderate or severe stenoses on two or three levels. The surgically treated 
patients had significantly more levels with severe stenoses (p<0.001) than the non-surgically 
treated with a higher level of compromise of the central zone (p=0.007), lesser cerebral spinal 
fluid to cauda ratio (p<0.001) and more compression in the lateral recession (p=0.022) (Table 
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2). In addition, concomitant degenerative spondylolisthesis was more common on levels 
L4/L5 (p=0.028) and L3/L4 (p=0.029) in the surgical group. 
Table 3 shows the proportion of operated levels for either moderate or severe stenotic 
levels in the surgical group. The rate of operation of severe stenotic levels was much higher 
compared to that of moderate stenotic levels (Odds ratio 14.2, 95% confidence interval 10.6 
to 19.3). The number of levels that underwent surgical decompression were correlated with 
the MRI grading of number of severely stenotic levels (correlation r = 0.88, p<0.001, 
Appendix Table 3). 
 
Non-surgical treatment 
Of the non-surgically treated patients, almost all received physiotherapy and/or analgesics 
(Table 4). During the study period, 23.4% received one corticosteroid injection (epidural, 
nerve root, or facet joints) and 53.2% of the patients had two or more injections. In the 
surgical group, almost half of the patients (44.2%) did not receive any injections whereas in 
the changers group all patients received at least one injection before surgery (Table 4). 
 
Surgical treatment types, surgical complications, and reoperations 
In the surgical group, 320 (77.7%) of the patients underwent surgical decompression alone 
and 92 (22.3%) a decompression with fusion surgery (Table 5). The most common 
intraoperative complication was a dural tear (6.1%). In total, 63 reoperations in 51 (12.4%) 
patients were performed, in 36 (11.3%) patients after decompression-alone surgery and 15 
(16.3%) patients after decompression and fusion surgery. Nine and three patients underwent 
two and three reoperations, respectively. The most common reason was a restenosis (73.0%) 
(Table 5). 
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The linear regression models of decompression alone surgery versus fusion surgery for 
SSM symptoms, SSM function, and EQ-5D-3L SI did not provide evidence that fusion 
surgery was associated with a more favorable clinical outcome (Appendix Table 4a-c). 
 
Clinical outcomes of different treatment strategies (surgical vs. non-surgical) 
Figure 2 depicts the overall course over time for the three treatment groups. At baseline the 
non-surgically treated patients did not differ significantly in regard to their SSM symptoms 
and SSM function scores and had only slightly higher scores for quality of life (EQ-5D-3L 
SI) compared to the patients in the surgical group. Over time however, surgically treated 
patients (except changers) performed significantly better in all clinical outcome measures 
(SSM symptoms, SSM function, and EQ-5D-3L SI; p<0.001, unadjusted) with a plateau at 
12-month follow-up staying constant until the follow-up end. The linear regression models 
for SSM symptoms, SSM function, and EQ-5D-3L SI confirmed that the surgically treated 
patients had better clinical outcomes at 36-month follow-up compared with the other two 
treatment groups (Appendix Table 5a-c). Overall, HADS and CIRS were negatively 
correlated with the here documented clinical outcome measures.  
In the surgical group 245 (67.1%) patients reported an MCID for SSM function, 265 
(72.6%) for SSM symptoms, and 224 (61.4%) for EQ-5D-3L SI. The corresponding numbers 
in the non-surgical group were 55 (37.4%), 76 (51.7%), and 45 (30.6%), and in the changers 
group 6 (35.3%), 9 (52.9%), and 5 (29.4%), respectively. 
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Discussion 
Patients who underwent surgical treatment of DLSS reported significantly better clinical 
outcomes – less pain and overall better function and quality of life – compared to patients 
with non-surgical treatment after three years. Two thirds of patients in the surgical group had 
a clinically relevant improvement in function, symptoms, and quality of life, compared to 
only about half of those in the non-surgical group in terms of symptoms and even less in 
terms of function and quality of life. On the other hand, one in eight patients in the surgical 
group had to be revised after initial surgery, mainly due to restenosis. Further, three percent 
of the initially non-surgically treated patient needed surgery within the period of observation. 
The optimal treatment strategy for patients with DLSS is still debated, in spite of a 
remarkable number of published studies.9,11-23 Although the authors of a recently published 
Cochrane review24 concluded that it is still uncertain whether surgical or non-surgical 
treatment leads to better results in individual patients. Three randomized trials (RCTs)11,12,19 
and two cohort studies14,16 provide evidence that surgery lead to better outcomes (up to five 
to six years) compared to non-surgical treatment. The results of our study are in agreement 
with those of these trials. In the SPORT study of Weinstein et al.11 a total of 654 patients 
were enrolled. The authors reported that the surgically treated patients improved more in all 
primary outcome measures than the non-surgically treated patients at 4-year follow-up. After 
eight years, there was no benefit of surgery in the randomized group any more, but in the 
observational group the results remained in favor for surgery.44 Malmivaara et al.19 concluded 
in their randomized study investigating a total of 94 patients that decompressive surgery 
yielded greater improvement than non-operative treatment at 2-year follow-up. After six 
years, there was a favorable difference in the Oswestry Disability Index (ODI) but not for leg 
or back pain.21 And in the RCT of Amundsen et al.12 100 patients were included and followed 
up to ten years with better clinical outcomes in the surgery group. In the cohort study of Atlas 
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et al.9,14 including 148 patients, surgical treatment resulted in greater improvement in patient-
reported outcomes at 4-year follow-up, but after 8 to 10 years only leg pain and back-related 
functional status remained in favor for the surgical treatment group. Chang et al.16 reported in 
their cohort study with 144 patients that surgically treated patients benefitted more than non-
surgically treated patients during the 10-year follow-up, but the positive effect diminished in 
the later years. Only the recently published RCT by Delitto et al.17 did not show a benefit for 
surgery compared to physiotherapy at 2-year follow-up. In short, surgical treatments – 
decompression techniques with and without fusion – seem to be more effective in regard to 
longer term improvement of symptoms but carry the disadvantages of potential early and late 
complications after surgery.4 
The main limitations of this study are the lack of standardization of decision processes for 
different treatment strategies and the non-random allocation of patients to surgical or non-
surgical treatment. To our knowledge there is no broadly accepted consensus on the 
indication for surgery or non-surgical treatment, except for a rapid deterioration of symptoms 
with neurological deficits. The decision for one of the treatment modalities was based on the 
judgement and recommendation of physicians and the preferences of patients. The unequal 
distribution of baseline characteristics between the surgical and non-surgical groups indicates 
that patients with more severe symptoms were operated. Patients in the surgical group 
suffered significantly more from buttocks and/or leg pain, reported more worsening 
symptoms over the last three months before enrollment in the study, responded poorer to pain 
medications, and had more levels with concomitant degenerative spondylolisthesis. This 
unequal distribution of baseline characteristics limits the comparison of treatment options; we 
believe the findings represent the reality of the clinical practice and decision making. We did 
not attempt to derive any causal treatment effect for surgical versus non-surgical therapy. 
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A second limitation is the non-random assignment of patients to one of the treatments. The 
aim of LSOS was not to prove the efficacy of surgery itself, compared to non-surgical 
treatment, but to observe a cohort of DLSS patient undergoing usual clinical care. It is 
important to note that the aforementioned RCTs11,12,17,19 had substantial difficulties with their 
adherence to protocol because not all patients received the assigned treatment and a 
remarkable proportion (43% to 57%)12,17,22 of patients who were allocated to non-surgical 
treatment did finally undergo surgery. We expect that in a future randomized trial there 
would be a similarly high change rate. 
There are still many questions unanswered about the optimal treatment of patients with 
DLSS. Many patients with DLSS have stenoses on more than one level. These 
multisegmental stenoses in the MRI are a major challenge for the surgeons. So far, MRI 
findings seem not to be very helpful to tell the surgeon which level(s) is (are) causal for the 
symptoms. These circumstances make it difficult to decide which stenoses the surgeon needs 
to decompress. Our findings suggest, that such a decision is particularly challenging with 
moderately but not severely stenotic levels. A further question is which patients benefit from 
decompression with fusion. 
With the above-mentioned limitations in mind, we conclude that surgical treatment of 
DLSS results in more favorable clinical outcomes with a sustained effect over time, 
compared to non-surgical treatment. 
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Figure 1: Study flow 
 
Figure 2: Overall course of all patients per treatment group over the study period 
Legend 2: SI, summary index; SSM, Spinal Stenosis Measure 
 
 
Copyright © 2020 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Table 1: Baseline patient characteristics 
Variable Surgical Non-Surgical Changers p-value 
n 412 171 18  
Age, years, mean (SD) 
   (decompression vs fusion, mean) 
72.25 (8.38) 
(73.30 vs 68.59) 
74.73 (8.50) 71.50 (9.84) 0.004 
Female, n (%) 208 (50.5) 97 (56.7) 7 (38.9) 0.207 
Civil Risk*, n (%) 141 (34.2) 69 (40.4) 2 (11.1) 0.035 
Compulsory Education, n (%) 106 (25.7) 40 (23.4) 5 (27.8) 0.811 
Employed, n (%) 57 (13.8) 17 (9.9) 3 (16.7) 0.389 
Current Smoker, n (%) 64 (15.6) 28 (16.6) 3 (16.7) 0.952 
BMI, kg/m2, mean (SD) 27.32 (4.65) 27.70 (5.60) 27.71 (3.67) 0.680 
Diabetes mellitus, n (%) 44 (10.7) 21 (12.4) 4 (22.2) 0.297 
Duration of symptoms > 6 months, n (%) 309 (75.0) 121 (70.8) 12 (66.7) 0.457 
Back pain, n (%) 351 (85.2) 149 (87.1) 14 (77.8) 0.531 
Buttocks pain, n (%) 327 (79.4) 119 (69.6) 12 (66.7) 0.026 
Leg pain, n (%) 372 (90.3) 139 (81.3) 17 (94.4) 0.007 
Muscle weakness, n (%) 266 (64.6) 105 (61.4) 9 (50.0) 0.384 
Numbness, n (%) 209 (50.7) 76 (44.4) 7 (38.9) 0.271 
Triggered by walking, n (%) 337 (81.8) 137 (80.1) 14 (77.8) 0.833 
Triggered by standing, n (%) 334 (81.1) 135 (78.9) 14 (77.8) 0.809 
Coxarthrosis, n (%) 61 (15.0) 35 (20.6) 6 (35.3) 0.036 
Gonarthrosis, n (%) 76 (18.7) 50 (29.6) 7 (41.2) 0.003 
Problem getting better or worse in the last 3 mo, n (%)    <0.001 
   Getting better 29 (7.0) 39 (22.9) 2 (12.5)  
   Staying about the same 65 (15.8) 43 (25.3) 4 (25.0)  
   Getting worse 315 (76.5) 88 (51.8) 8 (50.0)  
   Don’t know 3 (0.7) 0 (0.0) 2 (12.5)  
HADS Depression, mean (SD) 4.68 (3.37) 4.73 (3.32) 3.76 (3.03) 0.521 
CIRS, mean (SD) 9.32 (4.00) 9.47 (4.37) 9.06 (4.49) 0.885 
SSM function, mean (SD) 2.25 (0.67) 2.23 (0.78) 1.84 (0.53) 0.054 
SSM symptoms, mean (SD) 3.13 (0.61) 3.05 (0.70) 2.86 (0.61) 0.095 
EQ-5D-3L SI, mean (SD) 0.50 (0.30) 0.59 (0.32) 0.70 (0.24) <0.001 
SI, summary index; BMI, body mass index kg/m2; HADS, Hospital Anxiety and Depression Scale (range 0-21, best-worst; CIRS, 
Cumulative Illness Rating Scale (range 0-56, best-worst); SSM, Spinal Stenosis Measure  
* Living alone, or single/divorced/widowed and living in a nursing/residential home  
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Table 2: Radiologic evaluations of the MRIs 
Variable Surgical Non-surgical Changers p-value 
n 412 171 18  
Stenosis levels*, n (%)     
   L1/L2 81 (19.7) 40 (23.4) 3 (16.7) 0.547 
   L2/L3 203 (49.3) 91 (53.2) 8 (44.4) 0.606 
   L3/L4 310 (75.2) 126 (73.7) 15 (83.3) 0.658 
   L4/L5 366 (88.8) 154 (90.1) 14 (77.8) 0.289 
   L5/S1 174 (42.2) 78 (45.6) 5 (27.8) 0.322 
No. stenotic levels*, n (%)    0.076 
   0 3 (0.7) 4 (2.3) 0 (0.0)  
   1 62 (15.0) 32 (18.7) 3 (16.7)  
   2 111 (26.9) 27 (15.8) 6 (33.3)  
   3 126 (30.6) 51 (29.8) 7 (38.9)  
   4 78 (18.9) 35 (20.5) 1 (5.6)  
   5 32 (7.8) 22 (12.9) 1 (5.6)  
Compromise of the central zone*1, n (%)28 401 (97.3) 157 (91.8) 18 (100.0) 0.007 
Relation between fluid and cauda equina*1, n (%)29 369 (89.6) 124 (72.5) 14 (77.8) <0.001 
Nerve root compression in the lateral recess*1, n (%)30 393 (95.4) 153 (89.5) 16 (88.9) 0.022 
Compromise of the foraminal zone*1, n (%)28 384 (93.2) 156 (91.2) 17 (94.4) 0.677 
Foraminal nerve root impingement*1, n (%)31 268 (65.0) 110 (64.3) 12 (66.7) 0.974 
Highest stenotic grading*2, n (%)    NaN 
   None 0 (0.0) 0 (0.0) 0 (0.0)  
   Mild 3 (0.7) 4 (2.3) 0 (0.0)  
   Moderate 32 (7.8) 38 (22.2) 1 (5.6)  
   Severe 377 (91.5) 129 (75.4) 17 (94.4)  
Spondylolisthesis*3, n (%)     
   L1/L2 18 (4.4) 15 (8.8) 1 (5.6) 0.111 
   L2/L3 33 (8.0) 17 (9.9) 2 (11.1) 0.700 
   L3/L4 85 (20.6) 25 (14.6) 0 (0.0) 0.029 
   L4/L5 171 (41.5) 52 (30.4) 5 (27.8) 0.028 
   L5/S1 76 (18.4) 36 (21.1) 5 (27.8) 0.511 
* at least one moderate grading in one of the three core parameters, *1 at least one moderate grading on at least one of the five levels, *2 
highest grading in one of the three core parameters on all levels, *3 Meyerding listhesis grade ≥1  
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Table 3: Proportion of operated levels for either moderate or severe stenotic levels in the 
surgical group 
Level Moderate stenotic levels, n Moderate operated, n (%) Severe stenotic levels, n Severe operated, n (%) 
L1/L2 60 5 (8.3) 21 8 (38.1) 
L2/L3 117 25 (21.4) 86 72 (83.7) 
L3/L4 109 50 (45.9) 201 192 (95.5) 
L4/L5 74 51 (68.9) 292 274 (93.8) 
L5/S1 118 25 (21.2) 56 27 (48.2) 
 
 
Table 4: Non-surgical treatments per treatment group 
Treatment 
group 
Injections, 
n n (%) 
Physiotherapy 
only, n (%) 
Physiotherapy and 
analgesics, n (%) 
Analgesics 
only, n (%) 
No Physiotherapy 
or analgesics 
Surgical* 
0 182 (44.2) 14 (7.7) 81 (44.5) 60 (33.0) 27 (14.8) 
1 77 (18.7) 4 (5.2) 31 (40.3) 30 (39.0) 12 (15.5) 
2+ 153 (37.1) 9 (5.9) 92 (60.1) 47 (30.7) 5 (3.3) 
Non-
surgical 
0 40 (23.4) 3 (7.5) 30 (75.0) 7 (17.5) 0 (0.0) 
1 40 (23.4) 2 (5.0) 31 (77.5) 6 (15.0) 1 (2.5) 
2+ 91 (53.2) 1 (1.1) 75 (82.4) 14 (15.4) 1 (1.1) 
Changers* 
0 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
1 4 (22.2) 0 (0.0) 3 (75.0) 1 (25.0) 0 (0.0) 
2+ 14 (77.8) 1 (7.1) 9 (64.3) 4 (28.6) 0 (0.0) 
* non-surgical treatment before surgery 
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Table 5: Surgical treatments, surgical complications, and reoperations 
Variable Surgical Changers 
n 412 18 
Decompression alone, n (%) 320 (77.7) 12 (66.7) 
Fusion, n (%) 92 (22.3) 6 (33.3) 
   Multi-level fusion, n (%) 30 (7.3) 1 (5.6) 
Decompression level, n (%)   
   L1/L2 11 (2.7) 0 (0.0) 
   L2/L3 98 (23.8) 8 (44.4) 
   L3/L4 256 (62.1) 11 (61.1) 
   L4/L5 335 (81.3) 13 (72.2) 
   L5/S1 65 (15.8) 1 (5.6) 
Levels decompressed, n (%)   
   1 154 (37.4) 7 (38.9) 
   2 176 (42.7) 7 (38.9) 
   3+ 82 (19.9) 4 (22.2) 
Complications, n (%)   
   Intraoperative bleeding 4 (1.0) 0 (0.0) 
   Intraoperative dural tear 25 (6.1) 0 (0.0) 
   Postoperative wound infection 5 (1.2) 0 (0.0) 
   Postoperative osseous infection 1 (0.2) 0 (0.0) 
   Postoperative other* 34 (8.3) 1 (5.6) 
Days between baseline and operation, median [IQR] 18.00 [4.00, 46.00] 529.00 [418.25, 710.00] 
No. of reoperations in total, n 63 0 
   Patients with 1 reoperation, n (%) 51 (81.0) 0 (0.0) 
   Patients with 2 reoperations, n (%) 9 (14.3) 0 (0.0) 
   Patients with 3 reoperations, n (%) 3 (4.8) 0 (0.0) 
   Indication: restenosis 46 (73.0) 0 (0.0) 
   Indication: infection 1 (1.6) 0 (0.0) 
   Indication: epidural bleeding 2 (3.2) 0 (0.0) 
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Variable Surgical Changers 
   During the 1st year 35 (55.6) 0 (0.0) 
   During the 2nd year 20 (31.7) 0 (0.0) 
   During the 3rd year 8 (12.7) 0 (0.0) 
   Median days between baseline operation and 1st reoperation, (IQR) 309.00 [92.50, 568.50] 0 [0.0] 
   Median days between 1st reoperation and 2nd reoperation, (IQR) 282.00 [72.00, 332.00] 0 [0.0] 
   Median days between 2nd reoperation and 3rd reoperation, (IQR) 86.00 [46.50, 253.00] 0 [0.0] 
*e.g., urosepsis, hemorrhage, wound healing deficit 
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